Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Capnia (CAPN) Jumps 50% as Trading Resumes Following Merger Deal with Privately-Held Essentialis
December 27, 2016 9:17 AM ESTCapnia (NASDAQ: CAPN) resumed trading and is up 54% after the company and privately-held Essentialis, Inc. today announced their entry into a definitive merger agreement to create a rare disease therapeutics company. The combined company will be well-positioned to advance diazoxide choline controlled release... More
